Navigation Links
NuvaRing Blood-Clotting Victims Still Eligible to File Lawsuits Through Resource4thePeople
Date:2/9/2013

sed the findings of government research that put women who used the NuvaRing or other IUDs with a similar mixture of hormones at a 56 percent higher risk of suffering blood clotting that led to deep vein thrombosis and pulmonary embolisms than women on birth control pills.**

Resource4thePeople is committed to informing women about the risks they may face in their choices of contraception and to providing them data that ensures the protection of their health and that of any infants they may give birth to who may be exposed to side effects from contraceptive devices.

In announcing that free legal consultations are still being offered to women who may have suffered serious side effects from the use of the NuvaRing, Resource4thePeople notes that NuvaRing has now posted warnings about the increased risks of suffering blood clots on the company’s web site under the heading of “IMPORTANT SAFETY INFORMATION.***

Resource4thePeople recommends that women choosing a type of birth control review the company’s warning:

  •     The use of combination oral contraceptives is associated with increased risks of several serious side effects, including blood clots, stroke, or heart attack. NuvaRing is not for women with a history of these conditions. The risk of getting blood clots may be greater with the type of progestin in NuvaRing than with some other progestins in certain low-dose birth control pills. It is unknown if the risk of blood clots is different with NuvaRing use than with the use of certain birth control pills.
  •     NuvaRing is not for women with certain cancers or those who may be pregnant.
  •     NuvaRing does not protect against HIV infection and other sexually transmitted diseases.
  •     The most common side effects reported by NuvaRing users are: vaginal infections and irritation, vagin
    '/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
2. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
3. Law Firm Aggressively Litigating against Birth Control Makers for their Newer, but Allegedly Unsafer Products: Nuvaring, Yaz, BeYaz, Yasmin, Ocella, Gianvi
4. U-M sibling study discovers genetic region linked to control of key blood-clotting protein
5. Lung Cancer Asbestos Victims Center Now Urges Non Smokers To Call Them If They Now Have Lung Cancer And Were Exposed To Asbestos On The Job-Possible Major Compensation
6. Lung Cancer Asbestos Victims Center Urges Families Of Lung Cancer Victims To Ask The Victim If They Were Exposed To Asbesto On the Job And To Call Them If They Say-Yes
7. Mesothelioma Victims Center Now Fears Most US Nany Veterans Diagnosed With Mesothelioma Get Shortchanged So They Provide The Names Of The Best Mesothelioma Law Firms
8. Lung Cancer Asbestos Victims Center Urges All Individuals Diagnosed With Lung Cancer Who Had On The Job Exposure To Asbestos To Call Them About Financial Compensation
9. US Drug Watchdog Now Urges All Victims Of The Transvaginal Mesh Product Failure With Erosion To Call Them For The Names Of National Caliber Attorneys--Who are all Women
10. US Drug Watchdog Now Expands Their All Metal Hip Implant Initiative By Inviting The Top Personal Injury Law Firms In All States To Help Them Get More Victims Indentified
11. Mesothelioma Victims Center Now Offers Names And Contacts Of The Best Mesothelioma Law Firms For Diagnosed Former Shipyard Workers In CA, WA, VA and Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... ... June 29, 2015 , ... Assurex Health, a ... certain neuropsychiatric and chronic pain conditions, has announced appointments to three key leadership ... Peter Donato, Senior Vice President, Chief Financial Officer; Craig S. Lewis, Senior Vice ...
(Date:6/29/2015)... Fernando Valley, CA (PRWEB) , ... June 29, 2015 , ... ... non-invasive treatments designed to lift and tighten sagging skin. Ulthera is a special treatment ... surgery. Instead, it uses ultrasound technology to gently stimulate collagen production. Ulthera is highly ...
(Date:6/29/2015)... ... , ... The world’s fastest and highest flying production aircraft, the SR-71 Blackbird, ... Virginia. This iconic, supersonic stealth plane will become the focal point of the Museum’s ... ceiling of a historic train station is perhaps one of the most unconventional presentations ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... (Cognizin®) from Kyowa Hakko Bio to French consumers. , The specialized eye health ... oxidative stress caused by free radicals. In addition to Citicoline (Cognizin®), Biomacula provides ...
(Date:6/29/2015)... ... June 29, 2015 , ... Celebrities have many skincare secrets, and ... skin all summer long and beyond. People don’t have to be famous to ... aging process, maintain an even skin tone, avoid breakouts, and take skin health and ...
Breaking Medicine News(10 mins):Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 2Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 3Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 2Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 3Health News:SR-71 Prepares for Flight to Science Museum of Virginia 2Health News:Bionops Laboratory Releases Biomacula, the First French Product with Citicoline (Cognizin®) 2Health News:Bionops Laboratory Releases Biomacula, the First French Product with Citicoline (Cognizin®) 3Health News:Skin Guru Shares Celebrity FACE Secrets For Summer-Proofing The Skin 2Health News:Skin Guru Shares Celebrity FACE Secrets For Summer-Proofing The Skin 3
... half of people in 30s, 40s use them when with ... Six out of every 10 middle-aged Britons do not ... study shows. , Those numbers might be similar for Americans, ... and, given prevailing policies with regard to contraception, may ...
... More than 350 brain tumor patients,caregivers, friends and ... neuro-oncology, pathology and caregiving, for a day,of information, support, ... detection, at the 7th Annual Brain Tumor Awareness Day,Conference. ... Where: Schwartz Lecture Hall "F" ...
... Offer Licenses to Fundamental Fractional Patent Families, ... Nov. 11 ,Reliant Technologies, Inc. and Palomar ... formation of a Fractional Technology Open Patent,Program ... field to key,intellectual property in the fractional ...
... 11 Covance Inc. (NYSE:,CVD) today announced that it ... Thursday, November 13, 2008 at 1:30 pm (ET).,Investors may ... . In order to register and download any necessary,software, ... headquarters in Princeton, New Jersey, is one of the,world,s ...
... is now the number one online health destination site within the ... audience figures. The new numbers make the health property one of ... visitors. , ... BROOKLYN, N.Y. (Business Wire EON) ...
... NEW ROCHELLE, N.Y., Nov. 11 The American,electorate has ... American can do anything. We hope that the messages ... that any American can do anything.,That includes women. Lawrence ... The cabinet position is about economics. The,contributions of science ...
Cached Medicine News:Health News:Most Single Adults Not Using Condoms 2Health News:Most Single Adults Not Using Condoms 3Health News:Brain Tumor Awareness Day: Free Brain Scans to Promote Early Detection 2Health News:Reliant Technologies, and Palomar Medical Technologies, Announce Launch of a Fractional Technology Licensing Program 2Health News:Reliant Technologies, and Palomar Medical Technologies, Announce Launch of a Fractional Technology Licensing Program 3Health News:Reliant Technologies, and Palomar Medical Technologies, Announce Launch of a Fractional Technology Licensing Program 4Health News: Waterfront Media Announces Everyday Health Network is Number One Online Health Destination : First time in ten years comScore Media Metrix names a new leader in online health 2Health News:Statement From the Rosalind Franklin Society: Lawrence Summers Not the Right Choice for Cabinet Position in Obama Administration 2
(Date:6/29/2015)... TARRYTOWN, N.Y. , June 29, 2015 /PRNewswire/ ... today announced that the Proceedings of the ... a paper demonstrating that the Company,s proprietary VelociGene ... the rapid identification and preclinical validation of potential ... and treatment of Middle East Respiratory Syndrome (MERS). ...
(Date:6/29/2015)... June 29, 2015 The global insulin ... according to a new study by Grand View Research, Inc. Growing ... presence of high unmet needs in emerging markets such as ... expected to be two of the most significant growth drivers of ... as obesity and growing global geriatric population base are expected to ...
(Date:6/29/2015)... , June 29, 2015  VisionCare Ophthalmic ... visual prosthetic devices for the treatment of ... publication of "Long-Term (60-month) Results for the ... Stratified by Age in Patients with End-Stage ... . The 5-year data show substantial retention ...
Breaking Medicine Technology:Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 2Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 4Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 5Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 2Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 3Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 4Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 2Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 3Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 4Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 5
... Pharmaceutical companies are dramatically increasing their investments ... demands of a patient-empowered, data-driven, outcomes-focused future in ... company investment in smart phone apps, educational websites, ... increased 78%, as companies embrace a role that ...
... Inc. (Nasdaq: MLAB ) today announced that ... cash dividend of 12 cents per share of common ... record at the close of business on February 25, ... markets electronic instruments and disposables for industrial, pharmaceutical and ...
Cached Medicine Technology:Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 2Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 3Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 4Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 5
... Our Pacemaker Follow-Up Solution makes ... part of our Cardiac Monitoring Center, ... a day, seven days a week ... call any time they experience a ...
... its introduction, the PROTG® GPS™ ... System has delivered on a ... and confidence. PROTG GPS Stents ... new level by adding tantalum ...
Assay development using client's antibodies and antigens to meet diagnostic target...
Gold Labeling kit for antibodies, the Coat-Block-Run Conjugation Kit pH 8-11; contains 1 bottle each of 20 nm and 40 nm Naked Gold...
Medicine Products: